Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213711-14-000004

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ward Carter Julian Chief Financial Officer 2012-06-19 Grant or award · Options +150,000 150,000 D
Loading xslF345X03/primary_doc.xml…